标题
A critical role of mir-199a in the cell biological behaviors of colorectal cancer
作者
关键词
MiR-199a, Colorectal cancer, Cell lines, <em class=EmphasisTypeItalic >In vitro</em>, Hypoxia-inducible factor 1α, Vascular endothelial growth factor
出版物
Diagnostic Pathology
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-06-12
DOI
10.1186/s13000-015-0260-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening
- (2015) I. Stegeman et al. Cancer Epidemiology
- miR-199a-3p Inhibits Aurora Kinase A and Attenuates Prostate Cancer Growth
- (2014) Yi Qu et al. AMERICAN JOURNAL OF PATHOLOGY
- MiR-199a-5p Loss Up-Regulated DDR1 Aggravated Colorectal Cancer by Activating Epithelial-to-Mesenchymal Transition Related Signaling
- (2014) Yingbin Hu et al. DIGESTIVE DISEASES AND SCIENCES
- Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial
- (2014) Paula Berstad et al. GUT
- A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver
- (2014) Aras N. Mattis et al. HEPATOLOGY
- The Hypoxia-Inducible Epigenetic Regulators Jmjd1a and G9a Provide a Mechanistic Link between Angiogenesis and Tumor Growth
- (2014) J. Ueda et al. MOLECULAR AND CELLULAR BIOLOGY
- Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis
- (2014) H. P. Joshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erratum to: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
- (2013) Ganji Purnachandra Nagaraju et al. ANGIOGENESIS
- Overexpression of Hypoxia Inducible Factor-1 Alpha is an Independent Risk Factor for Recurrence After Curative Resection of Colorectal Liver Metastases
- (2013) Manabu Shimomura et al. ANNALS OF SURGICAL ONCOLOGY
- Inflammation Amplifier, a New Paradigm in Cancer Biology
- (2013) T. Atsumi et al. CANCER RESEARCH
- MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1α
- (2013) Gang Ding et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The roles of microRNAs on tuberculosis infection: Meaning or myth?
- (2013) Harapan Harapan et al. TUBERCULOSIS
- Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab
- (2013) Timothy J. Price et al. Cancer Medicine
- Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma
- (2012) Cardin Romilda et al. BMC CANCER
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer
- (2012) Ying Kong et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- microRNA expression profile in a large series of bladder tumors: Identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer
- (2012) Géraldine Pignot et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
- (2012) Wen Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β
- (2011) Masaaki Tsukigi et al. CANCER LETTERS
- Lentivirus-Mediated Overexpression of MicroRNA-199a Inhibits Cell Proliferation of Human Hepatocellular Carcinoma
- (2011) Xiao Qin Jia et al. CELL BIOCHEMISTRY AND BIOPHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started